142 related articles for article (PubMed ID: 37173705)
21. High inter-follicular spatial co-localization of CD8+FOXP3+ with CD4+CD8+ cells predicts favorable outcome in follicular lymphoma.
Hagos YB; Akarca AU; Ramsay A; Rossi RL; Pomplun S; Ngai V; Moioli A; Gianatti A; Mcnamara C; Rambaldi A; Quezada SA; Linch D; Gritti G; Yuan Y; Marafioti T
Hematol Oncol; 2022 Oct; 40(4):541-553. PubMed ID: 35451108
[TBL] [Abstract][Full Text] [Related]
22. Expression of pannexin1 in lung cancer brain metastasis and immune microenvironment.
Abdo R; Bholat A; Jackson-Boeters L; Johnston D; Penuela S; Zhang Q
Clin Neuropathol; 2023; 42(4):140-149. PubMed ID: 37073958
[TBL] [Abstract][Full Text] [Related]
23. A Th1-like CD4
Yanagihara A; Yamasaki S; Hashimoto K; Taguchi R; Umesaki T; Imai H; Kaira K; Nitanda H; Sakaguchi H; Ishida H; Kobayashi K; Horimoto K; Kagamu H
Cancer Res Commun; 2023 Jul; 3(7):1277-1285. PubMed ID: 37476074
[TBL] [Abstract][Full Text] [Related]
24. Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancer.
Parra ER; Zhang J; Jiang M; Tamegnon A; Pandurengan RK; Behrens C; Solis L; Haymaker C; Heymach JV; Moran C; Lee JJ; Gibbons D; Wistuba II
Nat Commun; 2023 Apr; 14(1):2364. PubMed ID: 37185575
[TBL] [Abstract][Full Text] [Related]
25. Function of CD8
Wei W; Su Y
Comput Biol Med; 2023 Jun; 160():106933. PubMed ID: 37156220
[TBL] [Abstract][Full Text] [Related]
26. ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer.
Xin S; Liu X; Li Z; Sun X; Wang R; Zhang Z; Feng X; Jin L; Li W; Tang C; Mei W; Cao Q; Wang H; Zhang J; Feng L; Ye L
Exp Hematol Oncol; 2023 May; 12(1):49. PubMed ID: 37221625
[TBL] [Abstract][Full Text] [Related]
27. Characterization of evolution trajectory and immune profiling of brain metastasis in lung adenocarcinoma.
Jiang T; Yan Y; Zhou K; Su C; Ren S; Li N; Hou L; Guo X; Zhu W; Zhang H; Lin J; Zhang J; Zhou C
NPJ Precis Oncol; 2021 Feb; 5(1):6. PubMed ID: 33580130
[TBL] [Abstract][Full Text] [Related]
28. Tumor-infiltrating lymphocytes make inroads in non-small-cell lung cancer.
Veatch JR; Simon S; Riddell SR
Nat Med; 2021 Aug; 27(8):1339-1341. PubMed ID: 34385706
[No Abstract] [Full Text] [Related]
29. Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer.
Barrera C; Corredor G; Viswanathan VS; Ding R; Toro P; Fu P; Buzzy C; Lu C; Velu P; Zens P; Berezowska S; Belete M; Balli D; Chang H; Baxi V; Syrigos K; Rimm DL; Velcheti V; Schalper K; Romero E; Madabhushi A
NPJ Precis Oncol; 2023 Jun; 7(1):52. PubMed ID: 37264091
[TBL] [Abstract][Full Text] [Related]
30. Stress response in tumor-infiltrating T cells is linked to immunotherapy resistance.
Nat Med; 2023 Jun; 29(6):1336-1337. PubMed ID: 37253923
[No Abstract] [Full Text] [Related]
31. B cell-rich niches support stem-like CD8
Silina K
Cancer Cell; 2023 May; 41(5):824-825. PubMed ID: 37160101
[TBL] [Abstract][Full Text] [Related]
32. Cell Simulation as Cell Segmentation.
Jones DC; Elz AE; Hadadianpour A; Ryu H; Glass DR; Newell EW
bioRxiv; 2024 Apr; ():. PubMed ID: 38712065
[TBL] [Abstract][Full Text] [Related]
33. Correction: Tim‑3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma.
Cai C; Xu YF; Wu ZJ; Dong Q; Li MY; Olson JC; Rabinowitz YM; Wang LH; Sun Y
World J Urol; 2023 Jul; 41(7):2001. PubMed ID: 37266684
[No Abstract] [Full Text] [Related]
34. Multiplex imaging reveals the architecture of the tumor immune microenvironment.
Zhang J; Song J; Sheng J; Bai X; Liang T
Cancer Biol Med; 2021 Oct; 18(4):949-54. PubMed ID: 34709000
[No Abstract] [Full Text] [Related]
35. Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing.
Xue Q; Peng W; Zhang S; Wei X; Ye L; Wang Z; Xiang X; Zhang P; Zhou Q
Front Immunol; 2023; 14():1148061. PubMed ID: 37187731
[TBL] [Abstract][Full Text] [Related]
36. Cancer-associated fibroblast classification in single-cell and spatial proteomics data.
Cords L; Tietscher S; Anzeneder T; Langwieder C; Rees M; de Souza N; Bodenmiller B
Nat Commun; 2023 Jul; 14(1):4294. PubMed ID: 37463917
[TBL] [Abstract][Full Text] [Related]
37. Defining and using immune archetypes to classify and treat cancer.
Combes AJ; Samad B; Krummel MF
Nat Rev Cancer; 2023 Jul; 23(7):491-505. PubMed ID: 37277485
[TBL] [Abstract][Full Text] [Related]
38. Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma.
Beckinger S; Daunke T; Aldag L; Krüger S; Heckl S; Wesch D; Schäfer H; Röcken C; Rahn S; Sebens S
Front Oncol; 2023; 13():1160824. PubMed ID: 37207152
[TBL] [Abstract][Full Text] [Related]
39. Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta.
O'Connor RA; Martinez BR; Koppensteiner L; Mathieson L; Akram AR
Front Immunol; 2023; 14():1221532. PubMed ID: 37520560
[TBL] [Abstract][Full Text] [Related]
40. Short-term outcomes of robot-assisted versus video-assisted thoracoscopic surgery for non-small cell lung cancer patients with neoadjuvant immunochemotherapy: a single-center retrospective study.
Pan H; Zou N; Tian Y; Zhu H; Zhang J; Jin W; Gu Z; Ning J; Li Z; Kong W; Jiang L; Huang J; Luo Q
Front Immunol; 2023; 14():1228451. PubMed ID: 37497221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
